Results 171 to 180 of about 900,918 (272)

Application of lateral supraclavicular incision in unilateral thyroid papillary carcinoma surgery. [PDF]

Braz J Otorhinolaryngol, 2022
Ren YX, Yang J, Sun WZ, Chen Y, Wu XF, Huang N, Li XJ.   +6 more
europepmc   +1 more source

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

Molecular Oncology, Volume 20, Issue 11, Page 2955-2973, November 2026.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce, Simone Bini, Marialuisa Sponziello, Giorgio Grani, Giulia Fiscon, Paola Paci, Lorenzo Farina, Rosa Falcone, Valentina Maggisano, Sebastiano Filetti, Cosimo Durante, Antonella Verrienti   +11 more
wiley   +1 more source

Double trouble: Tumor-to-tumor metastasis of breast cancer into a thyroid papillary carcinoma - Case report and review of literature. [PDF]

Int J Surg Case Rep
Jbali S, Amri A, Dhaha M, Jeridi L, Houcine Y, Kedous S.   +5 more
europepmc   +1 more source

Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAF^V600E , and ultrasound elastography. [PDF]

J Clin Ultrasound, 2022
Wang X, Xu F, Gao J, Agyekum EA, Sun H, Zhang G, Li X, Xiang H, Hu S, Qian X.   +9 more
europepmc   +1 more source

METTL7B‐Mediated m6A Modification of PLEKHA4 Suppresses Ferroptosis via Reducing AURKA Ubiquitination to Promote Papillary Thyroid Cancer Progression

Cancer Medicine, Volume 15, Issue 11, November 2026.
In PTC cells, METTL7B stabilizes PLEKHA4 mRNA through m6A modification; upregulated PLEKHA4 binds KLHL12 and inhibits KLHL12‐mediated ubiquitination and degradation of AURKA, thereby stabilizing AURKA protein. Elevated AURKA suppresses ferroptosis by upregulating GPX4 and xCT while downregulating ACSL4, leading to ferroptosis resistance and enhanced ...
Wei Lin, Kunlin Wu, Jinshu Chen, Zhaomei Yu, Huihao Zhang, Xiangjin Chen   +5 more
wiley   +1 more source

Mönckeberg sclerosis in patients with thyroid papillary carcinoma. [PDF]

Endocr Oncol
Venetsanaki V, Zisimopoulou E, Zouli C, Boudina M, Gkiouras K, Xirou P, Fotiadou A, Stamati M, Argyropoulou E, Chrisoulidou A.   +9 more
europepmc   +1 more source

A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma. [PDF]

Medicine (Baltimore), 2021
Wang T, Tian K, Ji X, Song F.
europepmc   +1 more source

High Level of Component C1q Binding Protein (C1QBP) is Associated With Poor Prognosis and Dysfunction of Mast Cells in Lung Adenocarcinoma

Cancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Component C1q binding protein (C1QBP) is known as an important regulator of mitochondrial plasticity and is involved in antitumor immune response in cancers. Nevertheless, its role in lung adenocarcinoma (LUAD) still remains largely unknown.
Wei Li, Guangnan Huang, Lizhong Zeng, Wenhui Dang, Ting Jiao, Yonghong Zhang, Mengying Zhang, Shuru Zhou, Liping Chen, Shuanying Yang   +9 more
wiley   +1 more source

Effect of long-stranded non-coding RNA-BANCR on the progression of thyroid papillary carcinoma and its mechanism. [PDF]

Discov Oncol
Yu J, Hong K, Yao L, Shi D, Zhang J.
europepmc   +1 more source

Genomic Alterations in Pulmonary Carcinoid Tumors: A Targeted Analysis of Gene Rearrangements and Oncogenic Mutations

Cancer Medicine, Volume 15, Issue 11, November 2026.
This study applied RNA‐based next‐generation sequencing to one of the largest cohorts of pulmonary carcinoid tumors analyzed to date and revealed rare yet potentially actionable gene rearrangements and variants, including alterations in ALK, BRAF, and EGFR.
Jenni Niinimäki, Soili Kytölä, Ari Ristimäki, Johanna Arola, Tiina Vesterinen   +4 more
wiley   +1 more source